You just read:

Profil Institute and HighTide Biopharmaceutical Announce a Strategic Partnership Focused on the Development of New Therapies for Diabetes and NAFLD/NASH

News provided by

Profil Institute for Clinical Research, Inc.

Jul 28, 2016, 05:00 ET